3,040
Views
22
CrossRef citations to date
0
Altmetric
Review Article

A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations

, , ORCID Icon, & ORCID Icon
Pages 315-324 | Received 29 Sep 2020, Accepted 25 Dec 2020, Published online: 28 Jan 2021

References

  • Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol. 2020;92(10):1755–1756.
  • Zhou L, Liu K, Liu HG. [Cause analysis and treatment strategies of “recurrence” with novel coronavirus pneumonia (COVID-19) patients after discharge from hospital]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(4):281–284.
  • Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020;80(5):e14–e17.
  • Xing Y, Mo P, Xiao Y, et al. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Euro Surveill. 2020;25(10):2000191.
  • Qu Y-M, Kang E-M, Cong H-Y. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19. Travel Med Infect Dis. 2020;34:101619.
  • Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020;323(15):1502–1503.
  • Li J, Zhang C, Wu Z, et al. The mechanism and clinical outcome of patients with corona virus disease 2019 whose nucleic acid test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):488.
  • World Health Organization. Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 17 January 2020. 2020.
  • Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594.
  • Zhang W, Du R-H, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389.
  • Elberry MH, Ahmed H. Occult SARS-CoV-2 infection; a possible hypothesis for viral relapse. Med Hypotheses. 2020;144:109980.
  • Mattiuzzi C, Henry BM, Sanchis-Gomar F, et al. SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis. Acta Bio-Medica: Atenei Parmensis. 2020;91(3):e2020014.
  • Zou Y, Wang BR, Sun L, et al. The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China. J Infect Dis. 2020;222(11):1784–1788.
  • Yuan B, Liu HQ, Yang ZR, et al. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep. 2020;10(1):11887.
  • Wu J, Liu X, Liu J, et al. Coronavirus disease 2019 test results after clinical recovery and hospital discharge among patients in China. JAMA Netw Open. 2020;3(5):e209759.
  • Kang YJ. South Korea’s COVID-19 infection status: from the perspective of re-positive test results after viral clearance evidenced by negative test results. Disaster Med Public Health Prep. 2020. DOI:10.1017/dmp.2020.168
  • Li Y, Hu Y, Yu Y, et al. Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu. J Med Virol. 2020;92(10):1938–1947.
  • Wang X, Xu H, Jiang H, et al. The clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020;hcaa178.
  • Zhu H, Fu L, Jin Y, et al. Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection. J Clin Lab Anal. 2020;34(7):e23392.
  • Chen X, Chen Z, Azman AS, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. medRxiv. 2020. DOI:10.1101/2020.09.11.20192773
  • Chen JX, Hu X, Chen J, et al. Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China. Aging (Albany NY). 2020;12(17):16675–16689.
  • Chen LZL, Chen ZH, Liu J, et al. Can elevated concentrations of ALT and AST predict the risk of ‘recurrence’ of COVID-19? Epidemiol Infect. 2020;148:e218.
  • Chen SLX, Feng H, Sun HY, et al. Epidemiological and clinical findings of short-term recurrence of severe acute respiratory syndrome coronavirus 2 ribonucleic acid polymerase chain reaction positivity in 1282 discharged coronavirus disease 2019 cases: a multicenter, retrospective, observational study. Open Forum Infect Dis. 2020;7(10):ofaa432.
  • Du H-W, Chen J-N, Pan X-B, et al. Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients. Eur J Clin Microbiol Infect Dis. 2020. DOI:10.1007/s10096-020-04024-1
  • He ST, Li J, Zhou X, et al. Positive RT-PCR test results in 420 patients recovered from COVID-19 in Wuhan: an observational study. Front Pharmacol. 2020;11:549117.
  • Lu JP, Xiong J, Liu Q, et al. Ke, C. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine. 2020;59:102960.
  • Shui T-J, Li C, Liu H-B, et al. Characteristics of recovered COVID-19 patients with recurrent positive RT-PCR findings in Wuhan, China: a retrospective study. BMC Infect Dis. 2020;20(1):749.
  • Zheng JZ, Chen R, Tang F, et al. Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: a prospective cohort study. PLoS Negl Trop Dis. 2020;14(8):e0008648.
  • Zheng KI, Wang XB, Jin XH, et al. A case series of recurrent viral RNA positivity in recovered COVID-19 Chinese patients. J Gen Intern Med. 2020;35(7):2205–2206.
  • Yuan J, Kou S, Liang Y, et al. Polymerase chain reaction assays reverted to positive in 25 discharged patients with COVID-19. Clin Infect Dis. 2020;71(16):2230–2232.
  • Tian M, Long Y, Hong Y, et al. The treatment and follow-up of “recurrence” with discharged COVID-19 patients: data from Guizhou, China. Environ Microbiol. 2020;22(8):3588–3592.
  • Ravioli S, Ochsner H, Lindner G. Reactivation of COVID-19 pneumonia: a report of two cases. J Infect. 2020;81(2):e72–e73.
  • Peng J, Wang M, Zhang G, et al. Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR. Am J Infect Control. 2020;48(6):725–726.
  • Fenner J, Min MS, Liu S, et al. A case of neonatal pemphigus vulgaris with co-existing BP180 autoantibodies. Pediatr Dermatol. 2020;37(1):241–243.
  • Lafaie L, Célarier T, Goethals L, et al. Recurrence or relapse of COVID-19 in older patients: a description of three cases. J Am Geriatr Soc. 2020;68(10):2179–2183.
  • Jiang M, Li Y, Han M, et al. Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19). J Infect. 2020;81(1):147–178.
  • Hu R, Jiang Z, Gao H, et al. Recurrent positive reverse transcriptase-polymerase chain reaction results for coronavirus disease 2019 in patients discharged from a hospital in China. JAMA Netw Open. 2020;3(5):e2010475.
  • Chen Y, Bai W, Liu B, et al. Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: report from a designated transfer hospital in Chongqing, China. J Infect Public Health. 2020;13(7):932–934.
  • Batisse D, Benech N, Botelho-Nevers E, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. 2020;81:816–846.
  • Zhang B, Liu S, Dong Y, et al. Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19). J Infect. 2020;81(2):e49–e52.
  • Bongiovanni M, Basile F. Re-infection by COVID-19: a real threat for the future management of pandemia? Infect Dis (Lond). 2020;52(8):581–582.
  • Tomassini S, Kotecha D, Bird PW, et al. Setting the criteria for SARS-CoV-2 reinfection – six possible cases. J Infect. 2020. DOI:10.1016/j.jinf.2020.08.011
  • Gidari A, Nofri M, Saccarelli L, et al. Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature. Eur J Clin Microbiol Infect Dis. 2021;40(1):1–12.
  • Gupta V, Bhoyar RC, Jain A, et al. Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa1451
  • Song KH, Kim DM, Lee H, et al. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19. Kor J Intern Med. 2020. DOI:10.3904/kjim.2020.325
  • Zhou X, Zhou J, Zhao J. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report. BMC Infect Dis. 2020;20(1):500.
  • Yoo SY, Lee Y, Lee GH, et al. Reactivation of SARS-CoV-2 after recovery. Pediatr Int. 2020;62(7):879–881.
  • Wang P. Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man. J Med Virol. 2020;93(2):592–594.
  • Loconsole D, Passerini F, Palmieri VO, et al. Recurrence of COVID-19 after recovery: a case report from Italy. Infection. 2020;48(6):965–963.
  • Liu F, Cai ZB, Huang JS, et al. Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up. Pathog Dis. 2020;78(4):ftaa031.
  • Györfi AH, Kopp M, May M, et al. Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis. Ann Rheumat Dis. 2020. DOI:10.1136/annrheumdis-2020-218258
  • Dou C, Xie X, Peng Z, et al. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19. Diabetes Res Clin Pract. 2020;166:108300.
  • Chen D, Xu W, Lei Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297–299.
  • Bentivegna E, Sentimentale A, Luciani M, et al. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient. J Med Virol. 2020;93(1):97–98.
  • Du W, Yu J, Liu X, et al. Persistence of SARS-CoV-2 virus RNA in feces: a case series of children. J Infect Public Health. 2020;13(7):926–931.
  • Alonso FOM, Sabino BD, Guimarães MAAM, et al. Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: Case report. J Med Virol. 2021;93(2):655–656.
  • Duggan NM, Ludy SM, Shannon BC, et al. A case report of possible novel coronavirus 2019 reinfection. Am J Emerg Med. 2020;39:256.e1-256.e3.
  • Wu S, Gao D, Zhang Y, et al. Follicular lymphoma with paraneoplastic pemphigus as the first symptom: a case report and review of the literature. Int J Clin Exp Pathol. 2020;13(7):1915–1923.
  • Geling T, Huaizheng G, Ying C, et al. Recurrent positive nucleic acid detection in a recovered COVID-19 patient: a case report and literature review. Respir Med Case Rep. 2020;31:101152.
  • He FL, Lei Q, Fan M, et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol. 2020;39(9):2803–2810.
  • van Beek N, Schumacher N, Rose C, et al. [Modern diagnostics of autoimmune bullous diseases]. Pathologe. 2020;41(4):317–325.
  • Liu F, Cai ZB, Huang JS, et al. Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2. J Microbiol Immunol Infect. 2020. DOI:10.1016/j.jmii.2020.07.017
  • Mardani M, Nadji SA, Sarhangipor KA, et al. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect. 2020;37:100732.
  • AlFehaidi A, Ahmad SA, Hamed E. SARS-CoV-2 re-infection: a case report from Qatar. J Infect. 2020. DOI:10.1016/j.jinf.2020.10.019
  • Bongiovanni M. COVID-19 re-infection in an healthcare worker. J Med Virol. 2020. DOI:10.1002/jmv.26565
  • Colson P, Finaud M, Levy N, et al. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2020. DOI:10.1016/j.jinf.2020.11.011
  • Coppola A, Annunziata A, Carannante N, et al. Late reactivation of SARS-CoV-2: a case report. Front Med (Lausanne). 2020;7:531.
  • Goldman JD, Wang K, Roltgen K, et al. Reinfection with SARS-CoV-2 and failure of humoral immunity: a case report. medRxiv. 2020. DOI:10.1101/2020.09.22.20192443
  • Lancman G, Mascarenhas J, Bar-Natan M. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia. J Hematol Oncol. 2020;13(1):131.
  • Ma BMH, Chan IFN, Tam GCW, et al. Case of “relapsing” COVID-19 in a kidney transplant recipient. Nephrology (Carlton, Vic). 2020;25(12):933–936.
  • Nachmias V, Fusman R, Mann S, et al. The first case of documented Covid-19 reinfection in Israel. IDCases. 2020;22:e00970.
  • Patrocínio de Jesus RS, Aliyeva R, Lopes E, et al. Reactivation of SARS-CoV-2 after asymptomatic infection while on high-dose corticosteroids. SN Compr Clin Med. 2020;2(11):2402–2404.
  • Tillett RL, Sevinsky JR, Hartley PD, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21(1):52–58.
  • To KK-W, Hung IF-N, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa1275
  • Liu BS, Zhang Y, Li W, et al. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cell Mol Immunol. 2020;17(10):1098–1100.
  • Kaur N, Gupta I, Singh H, et al. Epidemiological and clinical characteristics of 6635 COVID-19 patients: a pooled analysis. SN Compr Clin Med. 2020. DOI:10.1007/s42399-020-00393-y
  • Ota M. Will we see protection or reinfection in COVID-19? Nat Rev Immunol. 2020;20(6):351.
  • Ling Y, Xu S-B, Lin Y-X, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J. 2020;133(9):1039–1043.
  • Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–1494.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–1062.
  • Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179.
  • Carver C, Jones N. Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19 - CEBM [Internet]. CEBM 2020 [cited 20 Nov 2020]. Available from: https://www.cebm.net/covid-19/comparative-accuracy-of-oropharyngeal-and-nasopharyngeal-swabs-for-diagnosis-of-covid-19/
  • Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. Jama. 2020;323(18):1843–1844.
  • Zhang J-f, Yan K, Ye H-h, et al. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge. Int J Infect Dis. 2020;97:212–214.
  • Yilla M, Harcourt BH, Hickman CJ, et al. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res. 2005;107(1):93–101.
  • Li L, Wo J, Shao J, et al. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J Clin Virol. 2003;28(3):239–244.
  • Wang H, Mao Y, Ju L, et al. Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. Clin Chem. 2004;50(7):1237–1240.
  • Ravi D, Prabhu SS, Rao R, et al. Comparison of immunofluorescence and desmoglein enzyme-linked immunosorbent assay in the diagnosis of pemphigus: a prospective, cross-sectional study in a tertiary care hospital. Indian J Dermatol. 2017;62(2):171–177.
  • Hong Kong man was reinfected with Covid: study 2020. Available from: https://news.rthk.hk/rthk/en/component/k2/1545589-20200824.htm.
  • Joseph A. Scientists are reporting several cases of Covid-19 reinfection — but the implications are complicated; 2020. Available from: https://www.statnews.com/2020/08/28/covid-19-reinfection-implications/
  • Tillett R, Sevinsky J, Hartley P, et al. Genomic evidence for a case of reinfection with SARS-CoV-2: THELANCETID-D-20-05376; 2020. Available from: https://ssrn.com/abstract=3681489
  • Tirado SMC, Yoon K-J. Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 2003;16(1):69–86.
  • Galanti M, Shaman J. Direct observation of repeated infections with endemic coronaviruses. J Infect Dis. 2020. DOI:10.1093/infdis/jiaa392
  • Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals. Nature 2020;584:437–442.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.